(19)
(11) EP 4 798 208 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24809355.1

(22) Date of filing: 20.11.2024
(51) International Patent Classification (IPC): 
A61K 31/519(2006.01)
A61K 31/00(2006.01)
A61K 47/40(2006.01)
 A61K 9/00(2006.01)
A61K 47/22(2006.01)
A61P 7/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/519; A61P 7/02; A61K 9/0019; A61K 47/22; A61K 31/658; A61K 9/19; A61K 47/26; A61K 47/6951
 
C-Sets:
  1. A61K 31/519, A61K 2300/00;
  2. A61K 31/658, A61K 2300/00;
(86) International application number:
PCT/EP2024/082952
(87) International publication number:
WO 2025/108980 (30.05.2025 Gazette 2025/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 22.11.2023 WO PCT/EP2023/082766
23.11.2023 WO PCT/EP2023/082915

(71) Applicant: Hyloris Developments SA
4000 Liège (BE)

(72) Inventors:
  • PATIL, Atul
    4000 Liège (BE)
  • EECKHAOUDT, Sabine
    4000 Liège (BE)

(74) Representative: Patent 42 
5, rue Dicks
4081 Esch-zur-Alzette
4081 Esch-zur-Alzette (LU)

   


(54) INTRAVENOUS ADMINISTRATION OF TICAGRELOR COMPOSITIONS IN A PATIENT WHO WAS PREVIOUSLY ADMINISTERED AN OPIOID IN ORDER TO TREAT COAGULATION AND AVOID REDUCED TICAGRELOR UPTAKE